Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Heart failure with preserved ejection fraction (HFpEF) is a major public health problem that
has no proven effective treatment. This study will assess the effects of nebulized inhaled
nitrite administration on resting and exercise hemodynamics in patients with HFpEF referred
to the catheterization lab.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Aires Pharmaceuticals, Inc. National Heart, Lung, and Blood Institute (NHLBI)